arXiv introduces AI agent for scalable drug discovery workflows
Researchers on arXiv have released a new AI agent designed to automate parts of drug discovery. The system, described in a paper titled arXiv:2611.03832v1, uses large language models to translate user goals into automated workflows. It selects scientific tools, reviews results, and adjusts steps based on target objectives and evidence stored in a shared memory system.
Key points
- AI agent automates drug discovery workflows by linking LLMs to scientific tools and evidence
- Shared memory system stores molecules, structures, and results with provenance for traceability
- Benchmark tests show competitive performance with lower token use than expert-led or plain tool approaches
The agent reduces the need for manual intervention by processing entire collections of molecules at once. It supports tasks like molecule generation, property prediction, and compound searches. Benchmark tests against expert-led campaigns and other models show competitive performance with lower token use. The paper highlights its potential to scale drug discovery while maintaining traceability of computational work.
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Research
All →- Anthropic releases FlashProve open-source system for provable AI inference · 7 src
- Gemini and Claude debate AI personality, ending in a three-way tie · 1 src
- Tencent releases WeVisOne-VL, a 2B/4B open vision model for detection, OCR and matting · 1 src
- Lama-dt outperforms baselines on meta-world and mujoco · 1 src
- Researchers release Dory1.0-4B, a 4B-parameter looped model with 256K-token context · 1 src
Comments
via GitHub Discussions